e-learning
resources
Munich 2006
Tuesday 05.09.2006
Hypoxic and inflammatory insults to the pulmonary circulation.
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
S. Marinari, S. Gallina, M. L. Storto, A. D‘Intino, F. De Benedetto (Chieti, Italy)
Source:
Annual Congress 2006 - Hypoxic and inflammatory insults to the pulmonary circulation.
Session:
Hypoxic and inflammatory insults to the pulmonary circulation.
Session type:
Thematic Poster Session
Number:
3818
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Marinari, S. Gallina, M. L. Storto, A. D‘Intino, F. De Benedetto (Chieti, Italy). Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results). Eur Respir J 2006; 28: Suppl. 50, 3818
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002
Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
Source: Eur Respir J 2009; 34: 588
Year: 2009
Initial diagnosis of COPD: the role of primary care and when to refer
Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management
Year: 2006
Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
CT predictors of pulmonary hypertension in patients with severe COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Adequate use of pulmonary embolism clinical prediction rule in COPD patients
Source: Eur Respir J 2011; 37: 219-220
Year: 2011
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Initial results of the UK audit of chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2007; 30: Suppl. 51, 486s
Year: 2007
Value of ²GOLD² reversibility test criteria in detecting ²reversible² chronic obstructive pulmonary disease (COPD) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004
Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 55s
Year: 2005
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Problems hypodiagnostics of chronic obstructive pulmonary disease. Using the original questionnaire for early diagnostics of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013
An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept